We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Significance of estrogen receptor 1 (ESR-1) gene imbalances in colon and hepatocellular carcinomas based on tissue microarrays analysis.
- Authors
Tsiambas, Evangelos; Georgiannos, Stavros; Salemis, Nikolaos; Alexopoulou, Despoina; Lambropoulou, Sofia; Dimo, Blerta; Ioannidis, Ioannis; Kravvaritis, Christos; Karameris, Andreas; Patsouris, Efstratios; Dourakis, Spyridon; Georgiannos, Stavros N
- Abstract
Estrogen receptor alpha-encoded by ESR1 gene-overexpression correlates with prognosis and response to specific chemotherapy in breast adenocarcinoma cases. Mechanisms of ESR-1 deregulation in carcinomas remain under investigation. To analyze ESR1 in carcinomas of different histogenesis. Using tissue microarray technology, 172 primary carcinomas including breast ductal adenocarcinomas (n=60), hepatocellular carcinomas (n=52), and colon adenocarcinomas (n=60) were cored and re-embedded in three paraffin blocks. Initial diagnosis was based on liquid based cytology (LiquiPrep/ThinPrep). Immunohistochemistry and fluorescence in situ hybridization were performed. Quantitative evaluation of ER-a protein levels was assessed by applying digital image analysis. ER-a overexpression was observed in 41/60 (68.3%), 23/52 (44.2%) and 4/60 (6.6%) cases, respectively. ESR1 gene multiple copies were confirmed in 13/60 (21.6%) breast adenocarcinomas, but high amplification only in 8/13 (62.8%). Allelic absence was identified in 3/52 (5.7%) hepatocellular carcinomas, whereas colon adenocarcinomas demonstrated gene gains in 5/60 (8.3%) cases referred to chr 6 aneuploidy and not to amplification. ER-a overall expression was associated strongly to ESR1 gene copies only in breast carcinoma (P=0.036). ESR-1 gene overexpression happens frequently in breast cancer, but only a subset of them are high amplified cases correlated to increased response rates in hormonal therapy (tamoxifen). Absence of this mechanism in hepatocellular and colon carcinomas maybe is a negative factor for applying this therapy. This is a pattern of histo-genetic depended targeted therapeutic strategy.
- Subjects
SELECTIVE estrogen receptor modulators; ESTROGEN antagonists; GENES; HEREDITY; COLON (Anatomy); LIVER cancer; ADENOCARCINOMA; BREAST tumors; COLON tumors; COMPARATIVE studies; DIAGNOSTIC imaging; GENE amplification; HEPATOCELLULAR carcinoma; IMMUNOHISTOCHEMISTRY; LIVER tumors; RESEARCH methodology; MEDICAL cooperation; COMPUTERS in medicine; PROTEINS; RESEARCH; TUMOR classification; FLUORESCENCE in situ hybridization; EVALUATION research; TISSUE arrays; GENE expression profiling; TUMOR grading
- Publication
Medical Oncology, 2011, Vol 28, Issue 4, p934
- ISSN
1357-0560
- Publication type
Academic Journal
- DOI
10.1007/s12032-010-9554-8